NO953286L - Benstimulerende faktor - Google Patents

Benstimulerende faktor

Info

Publication number
NO953286L
NO953286L NO953286A NO953286A NO953286L NO 953286 L NO953286 L NO 953286L NO 953286 A NO953286 A NO 953286A NO 953286 A NO953286 A NO 953286A NO 953286 L NO953286 L NO 953286L
Authority
NO
Norway
Prior art keywords
gly
polypeptide
lys
ala
pro
Prior art date
Application number
NO953286A
Other languages
English (en)
Other versions
NO953286D0 (no
Inventor
Cherk Shing Tam
Original Assignee
Osteopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteopharm Ltd filed Critical Osteopharm Ltd
Publication of NO953286D0 publication Critical patent/NO953286D0/no
Publication of NO953286L publication Critical patent/NO953286L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En polypeptidsubstans som isoleres fra rotteserum og som, ved administrering til rotter som er ute av stand til å produsere PTH (paratyroidectomiserte rotter), frembringer en økning i den observerte hastighet for benmineralapposisjon. Stoffet har blitt isolert i to former, et første større polypeptid med en molekylvekt på ca. det dobbelte av et andre mindre polypeptid. De første elleve aminosyrer fra det mindre polypeptids sekvens er bestemt å være Gly Pro Gly Gly Ala Gly Glu Thr Lys Pro Ile. De første syv aminosyrer fra det større polypeptid er bestemt å være Gly Pro Gly Gly Ala Gly Glu. Det større polypeptid kan være dimeren av det mindre polypeptid. En nukleinsyreprobe som er basert på rottepeptidets aminosyresekvens ble benyttet for å gjennomsøke et fetalt humant cDNA-leverbibliotek. Et polypeptid ble således kjemisk syntetisert ifølge sekvensen Gly Ile Gly Lys Arg Thr Asn Glu His Thr Ala Asp Cys Lys Ile Lys Pro Asn Thr Leu His Lys Lys Ala Ala Glu Thr Leu Met Val Leu Asp Gin Asn Gin Pro. Benapposisjonshastigheten i rotter øker på en doseavhengig måte ved administrering av denne kjemisk syntetiserte forbindelse.
NO953286A 1993-03-12 1995-08-22 Benstimulerende faktor NO953286L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3138693A 1993-03-12 1993-03-12
US12021793A 1993-09-13 1993-09-13
PCT/CA1994/000144 WO1994020615A1 (en) 1993-03-12 1994-03-14 Bone stimulating factor

Publications (2)

Publication Number Publication Date
NO953286D0 NO953286D0 (no) 1995-08-22
NO953286L true NO953286L (no) 1995-10-25

Family

ID=26707172

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953286A NO953286L (no) 1993-03-12 1995-08-22 Benstimulerende faktor

Country Status (19)

Country Link
EP (1) EP0688360B1 (no)
JP (1) JP3733381B2 (no)
KR (1) KR960701201A (no)
CN (1) CN1119457A (no)
AT (1) ATE208818T1 (no)
AU (1) AU678441B2 (no)
BR (1) BR9406447A (no)
CA (1) CA2157901A1 (no)
CZ (1) CZ234295A3 (no)
DE (1) DE69429082T2 (no)
ES (1) ES2168295T3 (no)
FI (1) FI954252A0 (no)
HU (1) HUT73297A (no)
IL (1) IL108947A0 (no)
NO (1) NO953286L (no)
NZ (1) NZ262352A (no)
PL (1) PL182236B1 (no)
TW (1) TW385314B (no)
WO (1) WO1994020615A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US5880094A (en) * 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US6117839A (en) * 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US6693081B2 (en) 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
ES2320603T3 (es) 1997-07-30 2009-05-25 Emory University Sistemas de expresion, vectores, adn, proteinas de mineralizacion osea novedosos.
EP1015565B1 (en) 1997-09-19 2006-04-12 Metabolix, Inc. Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
WO2000075185A1 (en) * 1999-06-02 2000-12-14 Osteopharm Inc. Bone stimulating factor
MXPA02002251A (es) 1999-08-30 2003-08-20 Interleukin Genetics Inc Diagnosticos y terapeuticos para osteoporosis.
US6815421B1 (en) 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
CA2534365A1 (en) 2003-08-08 2005-02-17 Interleukin Genetics, Inc. Diagnostic and therapeutics for osteoporosis
DE602007008147D1 (de) * 2006-12-21 2010-09-09 Numat As Konsensus-peptid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128041A3 (en) * 1983-06-06 1986-12-03 David Jeston Baylink Polypeptides exhibiting skeletal growth factor activity
CA2020729A1 (en) * 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein

Also Published As

Publication number Publication date
DE69429082D1 (de) 2001-12-20
BR9406447A (pt) 1996-02-13
HU9502659D0 (en) 1995-11-28
FI954252A7 (fi) 1995-09-11
KR960701201A (ko) 1996-02-24
JP3733381B2 (ja) 2006-01-11
ATE208818T1 (de) 2001-11-15
CZ234295A3 (en) 1996-04-17
DE69429082T2 (de) 2002-07-25
CN1119457A (zh) 1996-03-27
CA2157901A1 (en) 1994-09-15
PL182236B1 (pl) 2001-11-30
AU678441B2 (en) 1997-05-29
EP0688360A1 (en) 1995-12-27
FI954252A0 (fi) 1995-09-11
JPH08508158A (ja) 1996-09-03
ES2168295T3 (es) 2002-06-16
IL108947A0 (en) 1994-06-24
HUT73297A (en) 1996-07-29
AU6179794A (en) 1994-09-26
NZ262352A (en) 1997-10-24
PL310617A1 (en) 1995-12-27
EP0688360B1 (en) 2001-11-14
WO1994020615A1 (en) 1994-09-15
NO953286D0 (no) 1995-08-22
TW385314B (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DE69117788T2 (de) Parathyroid-Hormon-Antagonisten
DE69323337T2 (de) Derivate des Parathormons
JP2902115B2 (ja) 新規アミリン作動薬ペプチドおよびその使用
US5665705A (en) Glucagon analogs with serine replacements
NO953286L (no) Benstimulerende faktor
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
IE57880B1 (en) Novel atrial peptide
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
RU2235099C2 (ru) Антагонистические аналоги рилизинг-гормона гормона роста (gh-rh), ингибирующие инсулиноподобные факторы роста (igf-i и-ii)
EP0672054A1 (en) A novel molecule which inhibits neuropeptide tyrosine biological function
DE68912775T2 (de) Polypeptid-verbindungen mit hormonwachstumsbefreiender wirkung.
US5814610A (en) Osteogenic growth oligopeptides and pharmaceutical compositions containing them
CA2248630A1 (en) Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
US20070287665A1 (en) Urotensin-II agonists and antagonists
AU8237187A (en) Derivatives of atrial natriuretic peptides
DE69829567T2 (de) Angiotensinderivate
EP0431113A1 (en) Atrial peptide derivatives
FUJII et al. Studies on Peptides. CLVI. Synthesis of Second Human Calcitonin Gene-Related Peptide (β-hCGRP) by Application of a New Disulfide-Bonding Reaction with Thallium (III) Trifluoroacetate
Güllner et al. Effect of porcine gastrin releasing peptide on anterior pituitary hormone release
JPH08269090A (ja) 新規ぺプチド
Ganeshan et al. Recognition of neuropeptides FMRFamide and LPLRFamide by chicken cerebellum avian pancreatic polypeptide binding sites
US6262230B1 (en) Analogs of thymosin α1
AU2005202153B2 (en) Urotensin-II agonists
DE4431121A1 (de) Herstellung von konformationsstabilisierten Calcitonin-Analoga mit erhöhter hypocalcämischer Wirkung in vivo
KR920700675A (ko) 발기 기능장해 치료용 약물(칼시토닌 유전자 관련 펩티드)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application